Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Furosemide × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 NET 1 Endocrine 1

Conditions

Parkinson Disease 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Lewy Body Disease 1 Congenital Hyperinsulinism 1 Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 3 Fluorodeoxyglucose F18 2 FAPI-46 2 fluorodopa F 18 1 entrectinib 1 dactolisib 1 Specimen Handling 1 Respiratory Therapy 1 Furosemide 1 Everolimus 1 4-chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04706910 2026-02-09

18F-DOPA II - PET Imaging Optimization

University of Alberta

Phase 3 Recruiting

CNSEndocrineNET

Brain Neoplasms, Neuroblastoma, Parkinson Disease, Neuroendocrine Tumors, Lewy Body Disease, Congenital Hyperinsulinism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡